TipRanks
Cooper Co (CH:CP60)
:CP60
Switzerland Market

Cooper Co (CP60) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CP60 Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
4 Buy
9 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Cooper
Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CP60 Stock 12 Month Forecast

Average Price Target

―
Based on 13 Wall Street analysts offering 12 month price targets for Cooper Co in the last 3 months. The average price target is CHF54.59 with a high forecast of CHF62.73 and a low forecast of CHF48.51. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF62.73Average Price TargetCHF54.59Lowest Price TargetCHF48.51
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CH:CP60
Stifel Nicolaus
Stifel Nicolaus
CHF58.55
Buy
―
Reiterated
10/01/26
Analysts Offer Insights on Healthcare Companies: Cooper Co (NASDAQ: COO), Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) and CervoMed (NASDAQ: CRVO)
William Blair Analyst forecast on CH:CP60
William Blair
William Blair
―
Hold
―
Downgraded
09/12/26
Cooper Companies downgraded to Market Perform from Outperform at William BlairCooper Companies downgraded to Market Perform from Outperform at William Blair
Mizuho Securities Analyst forecast on CH:CP60
Mizuho Securities
Mizuho Securities
CHF71.09→CHF62.73
Buy
―
Reiterated
09/11/26
Cooper Companies price target lowered to $75 from $85 at MizuhoCooper Companies price target lowered to $75 from $85 at Mizuho
Citi
CHF66.91→CHF50.18
Hold
―
Reiterated
09/11/26
Cooper Companies price target lowered to $60 from $80 at CitiCooper Companies price target lowered to $60 from $80 at Citi
Robert W. Baird Analyst forecast on CH:CP60
Robert W. Baird
Robert W. Baird
CHF71.09→CHF51.02
Hold
―
Downgraded
09/10/26
Cooper Companies downgraded to Neutral from Outperform at BairdCooper Companies downgraded to Neutral from Outperform at Baird
J.P. Morgan Analyst forecast on CH:CP60
J.P. Morgan
J.P. Morgan
CHF59.39→CHF48.51
Hold
―
Assigned
09/10/26
Cooper Companies price target lowered to $58 from $71 at JPMorganCooper Companies price target lowered to $58 from $71 at JPMorgan
Bank of America Securities Analyst forecast on CH:CP60
Bank of America Securities
Bank of America Securities
CHF66.91→CHF54.37
Hold
―
Downgraded
09/10/26
Cooper Co (COO) was downgraded to a Hold Rating at Bank of America Securities
Needham
CHF71.93→CHF61.06
Buy
―
Reiterated
09/10/26
Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)
KeyBanc
―
Hold
―
Reiterated
09/10/26
Analysts Conflicted on These Healthcare Names: Telix Pharmaceuticals (Other OTC: TLPPF) and Cooper Co (NASDAQ: COO)
UBS
CHF62.73→CHF55.2
Hold
―
Assigned
09/10/26
Cooper Companies price target lowered to $66 from $75 at UBSCooper Companies price target lowered to $66 from $75 at UBS
Piper Sandler Analyst forecast on CH:CP60
Piper Sandler
Piper Sandler
CHF71.93→CHF49.35
Hold
―
Downgraded
09/10/26
Cooper Companies downgraded to Neutral from Overweight at Piper SandlerCooper Companies downgraded to Neutral from Overweight at Piper Sandler
Jefferies Analyst forecast on CH:CP60
Jefferies
Jefferies
CHF71.09→CHF58.55
Buy
―
Reiterated
09/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on CH:CP60
Wells Fargo
Wells Fargo
CHF55.2→CHF51.02
Hold
―
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Brainsway (NASDAQ: BWAY), Cooper Co (NASDAQ: COO) and Arcus Biosciences (NYSE: RCUS)
Goldman Sachs Analyst forecast on CH:CP60
Goldman Sachs
Goldman Sachs
CHF57.71→CHF51.02
Sell
―
Reiterated
05/27/26
Cooper Companies price target lowered to $61 from $69 at Goldman SachsCooper Companies price target lowered to $61 from $69 at Goldman Sachs
Barclays Analyst forecast on CH:CP60
Barclays
Barclays
CHF86.15
Buy
―
Reiterated
03/24/26
Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), Viatris (VTRS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CH:CP60
Stifel Nicolaus
Stifel Nicolaus
CHF58.55
Buy
―
Reiterated
10/01/26
Analysts Offer Insights on Healthcare Companies: Cooper Co (NASDAQ: COO), Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) and CervoMed (NASDAQ: CRVO)
William Blair Analyst forecast on CH:CP60
William Blair
William Blair
―
Hold
―
Downgraded
09/12/26
Cooper Companies downgraded to Market Perform from Outperform at William BlairCooper Companies downgraded to Market Perform from Outperform at William Blair
Mizuho Securities Analyst forecast on CH:CP60
Mizuho Securities
Mizuho Securities
CHF71.09→CHF62.73
Buy
―
Reiterated
09/11/26
Cooper Companies price target lowered to $75 from $85 at MizuhoCooper Companies price target lowered to $75 from $85 at Mizuho
Citi
CHF66.91→CHF50.18
Hold
―
Reiterated
09/11/26
Cooper Companies price target lowered to $60 from $80 at CitiCooper Companies price target lowered to $60 from $80 at Citi
Robert W. Baird Analyst forecast on CH:CP60
Robert W. Baird
Robert W. Baird
CHF71.09→CHF51.02
Hold
―
Downgraded
09/10/26
Cooper Companies downgraded to Neutral from Outperform at BairdCooper Companies downgraded to Neutral from Outperform at Baird
J.P. Morgan Analyst forecast on CH:CP60
J.P. Morgan
J.P. Morgan
CHF59.39→CHF48.51
Hold
―
Assigned
09/10/26
Cooper Companies price target lowered to $58 from $71 at JPMorganCooper Companies price target lowered to $58 from $71 at JPMorgan
Bank of America Securities Analyst forecast on CH:CP60
Bank of America Securities
Bank of America Securities
CHF66.91→CHF54.37
Hold
―
Downgraded
09/10/26
Cooper Co (COO) was downgraded to a Hold Rating at Bank of America Securities
Needham
CHF71.93→CHF61.06
Buy
―
Reiterated
09/10/26
Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)
KeyBanc
―
Hold
―
Reiterated
09/10/26
Analysts Conflicted on These Healthcare Names: Telix Pharmaceuticals (Other OTC: TLPPF) and Cooper Co (NASDAQ: COO)
UBS
CHF62.73→CHF55.2
Hold
―
Assigned
09/10/26
Cooper Companies price target lowered to $66 from $75 at UBSCooper Companies price target lowered to $66 from $75 at UBS
Piper Sandler Analyst forecast on CH:CP60
Piper Sandler
Piper Sandler
CHF71.93→CHF49.35
Hold
―
Downgraded
09/10/26
Cooper Companies downgraded to Neutral from Overweight at Piper SandlerCooper Companies downgraded to Neutral from Overweight at Piper Sandler
Jefferies Analyst forecast on CH:CP60
Jefferies
Jefferies
CHF71.09→CHF58.55
Buy
―
Reiterated
09/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on CH:CP60
Wells Fargo
Wells Fargo
CHF55.2→CHF51.02
Hold
―
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Brainsway (NASDAQ: BWAY), Cooper Co (NASDAQ: COO) and Arcus Biosciences (NYSE: RCUS)
Goldman Sachs Analyst forecast on CH:CP60
Goldman Sachs
Goldman Sachs
CHF57.71→CHF51.02
Sell
―
Reiterated
05/27/26
Cooper Companies price target lowered to $61 from $69 at Goldman SachsCooper Companies price target lowered to $61 from $69 at Goldman Sachs
Barclays Analyst forecast on CH:CP60
Barclays
Barclays
CHF86.15
Buy
―
Reiterated
03/24/26
Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), Viatris (VTRS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
WSTWest Pharmaceutical Services
ZYMEZymeworks
SLDBSolid Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cooper Co

3 Months
Anthony PetroneMizuho Securities
Success Rate
18/33 ratings generated profit
55%
Average Return
+2.39%
Copying Anthony Petrone's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +2.39% per trade.
1 Year
Anthony PetroneMizuho Securities
Success Rate
20/33 ratings generated profit
61%
Average Return
+2.99%
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 60.61% of your transactions generating a profit, with an average return of +2.99% per trade.
2 Years
Anthony PetroneMizuho Securities
Success Rate
14/33 ratings generated profit
42%
Average Return
-1.94%
Copying Anthony Petrone's trades and holding each position for 2 Years would result in 42.42% of your transactions generating a profit, with an average return of -1.94% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CP60 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
9
8
9
6
7
Hold
6
7
6
12
10
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
16
16
15
18
17
In the current month, CP60 has received 7 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. CP60 average Analyst price target in the past 3 months is 54.59.
Each month's total comprises the sum of three months' worth of ratings.

CP60 Financial Forecast

CP60 Earnings Forecast

Next quarter’s earnings estimate for CP60 is CHF0.90 with a range of CHF0.88 to CHF1.03. The previous quarter’s EPS was CHF0.96. CP60 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CP60 has Performed in-line its overall industry.
Next quarter’s earnings estimate for CP60 is CHF0.90 with a range of CHF0.88 to CHF1.03. The previous quarter’s EPS was CHF0.96. CP60 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CP60 has Performed in-line its overall industry.

CP60 Sales Forecast

Next quarter’s sales forecast for CP60 is CHF893.31M with a range of CHF887.77M to CHF899.14M. The previous quarter’s sales results were CHF891.78M. CP60 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CP60 has Performed in-line its overall industry.
Next quarter’s sales forecast for CP60 is CHF893.31M with a range of CHF887.77M to CHF899.14M. The previous quarter’s sales results were CHF891.78M. CP60 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CP60 has Performed in-line its overall industry.

CP60 Stock Forecast FAQ

What is CH:CP60’s average 12-month price target, according to analysts?
Based on analyst ratings, Cooper Co’s 12-month average price target is 54.59.
    What is CH:CP60’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CP60, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cooper Co a Buy, Sell or Hold?
        Cooper Co has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 9 hold ratings and 0 sell ratings.
          What is Cooper Co’s share price target?
          The average share price target for Cooper Co is 54.59. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF62.73 ,and the lowest forecast is CHF48.51. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cooper Co?
            Cooper Co’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Cooper Co?
              To buy shares of CH:CP60, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.